A nanotherapeutic approach to selectively eliminate metastatic breast cancer cells by targeting cell surface GRP78.
Journal
Nanoscale
ISSN: 2040-3372
Titre abrégé: Nanoscale
Pays: England
ID NLM: 101525249
Informations de publication
Date de publication:
17 Aug 2023
17 Aug 2023
Historique:
medline:
21
8
2023
pubmed:
1
8
2023
entrez:
1
8
2023
Statut:
epublish
Résumé
Here, rational engineering of doxorubicin prodrug loaded peptide-targeted liposomal nanoparticles to selectively target metastatic breast cancer cells
Substances chimiques
Endoplasmic Reticulum Chaperone BiP
0
Membrane Proteins
0
Prodrugs
0
Glucose
IY9XDZ35W2
Peptides
0
Doxorubicin
80168379AG
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM